372 related articles for article (PubMed ID: 28296190)
21. MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
Li C; Du X; Xia S; Chen L
Oncol Rep; 2018 Jul; 40(1):252-260. PubMed ID: 29750311
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA‑199a‑5p suppresses cell proliferation, migration and invasion by targeting ITGA3 in colorectal cancer.
Tian L; Chen M; He Q; Yan Q; Zhai C
Mol Med Rep; 2020 Sep; 22(3):2307-2317. PubMed ID: 32705201
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
Cong K; Li CG; Wei YH; Zhang K; Xu HB
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
27. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
28. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
29. OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Xia L; Gao J; Ma K; Lin H; Chen Y; Luo Q; Lian J
Pathol Res Pract; 2021 Aug; 224():153493. PubMed ID: 34098198
[TBL] [Abstract][Full Text] [Related]
30. KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.
Bian Y; Gao G; Zhang Q; Qian H; Yu L; Yao N; Qian J; Liu B; Qian X
Cancer Biol Ther; 2019; 20(6):886-896. PubMed ID: 30794031
[TBL] [Abstract][Full Text] [Related]
31. MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.
Wang WX; Yu HL; Liu X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6467-6477. PubMed ID: 31378886
[TBL] [Abstract][Full Text] [Related]
32. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
Liu Y; Liu R; Yang F; Cheng R; Chen X; Cui S; Gu Y; Sun W; You C; Liu Z; Sun F; Wang Y; Fu Z; Ye C; Zhang C; Li J; Chen X
Mol Cancer; 2017 Mar; 16(1):53. PubMed ID: 28257633
[TBL] [Abstract][Full Text] [Related]
33. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.
Li G; Xu Y; Wang S; Yan W; Zhao Q; Guo J
Pathol Res Pract; 2019 Jan; 215(1):34-39. PubMed ID: 30455125
[TBL] [Abstract][Full Text] [Related]
34. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT
Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
Yu B; Liu X; Chang H
Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
[TBL] [Abstract][Full Text] [Related]
36. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
37. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
Ma ZH; Shi PD; Wan BS
Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196
[TBL] [Abstract][Full Text] [Related]
38.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
39. Aloperine inhibits colorectal cancer cell proliferation and metastasis progress via regulating miR-296-5p/STAT3 axis.
Han W; Kong D; Lu Q; Zhang W; Fan Z
Tissue Cell; 2022 Feb; 74():101706. PubMed ID: 34883316
[TBL] [Abstract][Full Text] [Related]
40. Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT.
Xu Y; Pan ZG; Shu L; Li QJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8664-8674. PubMed ID: 30575907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
